Home » Topics » BioWorld Science

BioWorld Science
RSS

Medshine Discovery discovers ketohexokinase inhibitors

July 28, 2021

Grunenthal begins phase I trial of glucocorticoid receptor modulator

July 27, 2021

Xenon Pharmaceuticals targets Nav1.5 with aryl sulfonamide inhibitors

July 27, 2021

First-in-human safety and PK data reported for pirepemat

July 27, 2021

Inhalable human ACE2-containing nanocatchers may protect host cells from SARS-CoV-2 infection

July 27, 2021

Enrollment opens in phase I study of BI-1569912 for major depressive disorder

July 27, 2021

Responses seen with personalized neoantigen peptide vaccine in NSCLC patients with EGFR mutations

July 27, 2021

Inozyme opens enrollment in phase I/II study of INZ-701 for ENPP1 deficiency

July 27, 2021

XWPharma starts first-in-human study of XW-10508

July 27, 2021

Leo Pharma begins phase IIa study of LEO-138559 for moderate to severe atopic dermatitis

July 27, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...